• Fund Type: FCP
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: -

DekaLux-BioTech

+ Add to Watchlist

DKXBITF:LX

239.33 EUR 5.50 2.35%

As of 00:59:30 ET on 04/17/2014.

Snapshot for DekaLux-BioTech (DKXBITF)

Year To Date: -2.56% 3-Month: -11.56% 3-Year: +26.16% 52-Week Range: 190.17 - 296.17
1-Month: -11.92% 1-Year: +24.23% 5-Year: +20.88% Beta vs LUXXX: 0.61

Mutual Fund Chart for DKXBITF

No chart data available.
  • DKXBITF:LX 239.33
  • 1M
  • 1Y
Interactive DKXBITF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DKXBITF

DekaLux-BioTech is an open-end fund incorporated in Luxembourg. The objective is growth. The Fund invests in equity securities worldwide, that are issued by companies involved in the discovery, research, development, production, distribution, and marketing of biotechnological products for medical applications.

Inception Date: 06-02-2008 Telephone: 352-3409-39 Tel
Managers: ROGER VOGT
Web Site: -

Fundamentals for DKXBITF

NAV (on 2014-04-17) 239.33
Assets (M) (on 2014-04-17) 175.09
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for DKXBITF

Dividend Type Omitted
Dividend Frequency Annual
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for DKXBITF

Front Load 0.00
Back Load -
Current Mgmt Fee 1.25
Redemption Fee -
12b1 Fee -
Expense Ratio 2.19

Top Fund Holdings for DKXBITF

Filing Date: 12/30/2013
Name Position Value % of Total
Biogen Idec Inc 72,950 14,713,047 8.197%
Gilead Sciences Inc 257,850 13,968,923 7.783%
Celgene Corp 111,020 13,647,060 7.603%
Amgen Inc 142,649 11,949,524 6.658%
Regeneron Pharmaceuticals Inc 52,270 10,537,221 5.871%
Alexion Pharmaceuticals Inc 72,100 6,902,767 3.846%
Mylan Inc/PA 217,500 6,770,662 3.772%
Illumina Inc 71,250 5,722,771 3.188%
Vertex Pharmaceuticals Inc 103,350 5,523,742 3.077%
BioMarin Pharmaceutical Inc 79,800 4,021,182 2.240%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil